{
    "CONTRACT_ID": "cb-3894-70489984",
    "type": "Tender Notice",
    "department": "",
    "procurement_category": "Goods and Services (General)",
    "short_summary": "Subscription to PRA, PF and CD&H - IQVIA",
    "description": "The PMPRB requires drug information respecting quantities and revenue of medicines sold in Canada.",
    "estimated_value": 0,
    "date_posted": "2023-02-17",
    "duration_in_months": ", 2023-03-29",
    "provinces": [
        "Ontario"
    ],
    "tags": [],
    "full_summary": "### Subscription Service to Support Patented Medicine Prices Review Board's Operations\n#### Call for Tenders\n\n**Reference Number:** cb-3894-70489984\n**Publication Date:** 2023-02-17\n**Tender Closing Date:** 2023-03-29T14:00:00\n**Amendment Number:** 1\n**Solicitation Number:** SN23002\n\nThe Patented Medicine Prices Review Board (PMPRB) is seeking the services of a vendor to provide a subscription to a comprehensive database that offers information related to patented medicines sold in Canada. This tender is part of the PMPRB's ongoing efforts to collect and analyze data on the quantities and revenues generated from sales of patented medications.\n\n**Scope of Work:**\n\nThe selected vendor will provide regular updates on federal and provincial/territorial policy changes affecting pharmaceuticals, public drug plan design and coverage, price fluctuations, and developments within the Common Drug Review. Additionally, the vendor will furnish information on the latest Notice of Compliance, statistical data, and intelligence on the Canadian pharmaceutical market.\n\n**Key Requirements:**\n\n* Comprehensive database of patented medicines sold in Canada\n* Information on quantities and revenues generated from sales\n* Regular updates on federal and provincial/territorial policy changes\n* Publications and associated subscription services for policy changes related to pharmaceuticals\n* Data on drug prices, public drug plan design and coverage, and the Common Drug Review\n* Intelligence on the Canadian pharmaceutical market\n\n**Notice URL:** None\n**Attachment URL:** <https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/3894/sn23002-acan-eng.pdf> (English), <https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/3894/sn23002-acan-fr.pdf> (French)\n\n**Evaluation Criteria:** The proposal will be evaluated based on the vendor's ability to meet the technical requirements outlined above.\n\n**Selection Criteria:** [Insert selection criteria or evaluation factors]\n\n**Commercial Trade Agreements:** This procurement may be subject to Canada's Trade Agreements, including:\n\n* Canada-Ukraine Free Trade Agreement (CUFTA)\n* Canada-Chile Free Trade Agreement (CCFTA)\n* World Trade Organization Agreement on Government Procurement (WTO GPA)\n* Canada-Panama Free Trade Agreement\n* Canadian Free Trade Agreement (CFTA)\n* Canada-Peru Free Trade Agreement (CPFTA)\n* Canada-Korea Free Trade Agreement (CKFTA)\n* Canada-Honduras Free"
}